✦ LIBER ✦

A probucol analog protects lipoproteins better than probucol

✍ Scribed by L. F. Dmitriev; M. V. Ivanova

Book ID: 110551196
Publisher: Springer US
Year: 1995
Tongue: English
Weight: 262 KB
Volume: 119
Category: Article
ISSN: 0007-4888
DOI: 10.1007/bf02543433

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Probucol protects lipoprotein(a) against

Probucol protects lipoprotein(a) against oxidative modification

✍ Marek Naruszewicz; Elizabeth Selinger; Robert Dufour; Jean Davignon 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 548 KB

Probucol protects low-density lipoprotei

Probucol protects low-density lipoproteins from in vitro and in vivo oxidation

✍ Gabriele Bittolo-Bon; Giuseppe Cazzolato; Pietro Avogaro 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 542 KB

Lack of effect of probucol on serum lipo

Lack of effect of probucol on serum lipoprotein(a) levels

✍ Satoshi Maeda; Masataka Okuno; Akira Abe; Akio Noma 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 206 KB

MDL 29311, an analog of probucol, decrea

MDL 29311, an analog of probucol, decreases triglycerides in rats by increasing hepatic clearance of very-low-density lipoprotein

✍ Matthew J. Sheetz; Roger L. Barnhart; Richard L. Jackson; Keith M. Robinson 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 984 KB

Effect of probucol on the physical prope

Effect of probucol on the physical properties of low-density lipoproteins oxidized by copper

✍ McLean, Larry R.; Hagaman, Karen A. 📂 Article 📅 1989 🏛 American Chemical Society 🌐 English ⚖ 901 KB

High-density lipoprotein and apolipoprot

High-density lipoprotein and apolipoprotein A-I deficiency induced by combination therapy with probucol and bezafibrate

✍ K. Saku; B. Zhang; S. Jimi; H. Bai; K. Hirata; N. Sasaki; R. Liu; K. Arakawa 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 776 KB

The effects of the administration of slowrelease bezafibrate to hypercholesterolaemic patients who were already receiving long-term probucol treatment (mean 865 days, 500-1000 mg'day-1) were investigated. Bezafibrate was administered at either 200 tug'day 1 (13 males, 13 females, mean age 55.2 years